The Chamber of Commerce of Metropolitan Montreal

Secure and simple sign-up

  • Visa
  • Mastercard
  • American Express
We respect your privacy

Life sciences

A wealth-generating sector and an engine of prosperity for Quebec Events The activity will be held in French and English

Principal Sponsor

Learn more about a sector with high potential

A largely untapped key sector for Montreal, the life sciences sector can boast new infrastructure in 2016, and is poised to become a global leader in the field of medical research. The business models have undergone a change and major international pharmaceutical companies are now more than ever working with SMEs and research centres, of which there are an abundance in Quebec and its metropolis. The life sciences and health technology (LSHT) sector is growing, and the industry’s contribution to the province’s GDP is comparable to that of the aerospace industry.

By taking part in this forum, you will:

  • understand the economic importance of the life sciences sector for the city and for the province of Quebec
  • learn more about Montreal’s strategic position as a hub for research and innovation
  • explore successful strategies for growth in this and forward-looking industry
  • establish contacts with the sector’s key players.

Political decision-makers, sector representatives, and businesspeople are invited to attend this forum that will shed some light on this industry’s important contribution to the city.

The life sciences and health technology (LSHT) industry in the Greater Montreal area:

  • is made up of 600 organizations, including 150 research centres and 80 subsidiaries of world-class foreign companies
  • includes 40,000 jobs, putting it in 7th place in North America in terms of employment concentration
  • has the most competitive operating costs among major North American cities.
Source: Montréal InVivo, 2016


Do not miss this event which will take place in the presence of:

  • Dominique Anglade Minister of Economy, Science and Innovation
    Minister responsible for the Digital Strategy
For the program, click here.

 

Prices

Members Non members
Ticket(s) Ticket(s) $350 * $450 *
Table(s) of 10 Table(s) of 10 $3150 * $4500 *

Contact et informations

By phone:

514 871-4001

For more information

info@ccmm.ca
No reservations, cancellations or refunds after the registration deadline. Participant substitutions are accepted at no extra charge until the event is held. Please note that only cancellation notices sent by email at reservations@ccmm.ca will be accepted.

Location

Palais des congrès de Montréal

1001 Place Jean-Paul-Riopelle
Montréal, QC
H2Z 1H5

Place-d'Armes

Get directions

Program:

Opening Remarks

  • Michel LeblancPresident and CEO
    Chamber of Commerce of Metropolitan Montreal
  • Gaétan MorinPresident and CEO
    Fonds de solidarité FTQ

Minister’s Speech

  • Dominique Anglade Minister of Economy, Science and Innovation
    Minister responsible for the Digital Strategy

Part I – The LSHT industry: an instrument of prosperity for québec and its metropolis

Québec and its metropolis: world-class players

  • Frank BéraudChief Executive Officer
    Montréal InVivo
  • Sébastien AdamSenior Director
    Roland Berger

Prospering in a new business environment

  • Frederic AlberroDirector, Québec
    Innovative Medicines Canada

Commercialization of innovation: a major challenge

  • Neil FraserPresident
    Medtronic du Canada

For a better integration of innovation in the health system

  • Rémi QuirionChief Scientist
    Gouvernement du Québec

Part II – Focusing on our pillars to speed up growth in the LSHT industry

Montreal: center of research and innovation

  • Jean-Claude TardifDirector of the Research Centre
    Montréal Heart Institute

Funding to maximize R&D spin-offs

  • Didier LeconteSenior Director, Investments, Life Sciences Sector
    Fonds de solidarité FTQ
  • Louise Proulx, PhD.Venture Partner
    Sanderling
  • Pierre FalardeauPresident and CEO
    Verlyx Pharma

Consolidating partnerships: building bridges between research and industry needs

  • Philippe WalkerChief Scientific Officer
    NÉOMED
  • Diane CôtéPresident and CEO
    MEDTEQ
  • Nadine BeaugerChief Executive Officer
    IRIC - commercialisation de la recherche
  • Claude ChevalierFounder and Chairman of the Board
    Bio-K+

Part III – Future prospects and opportunities to be seized

Promoting the attractiveness and competitiveness of the LSHT sector internationally

  • Christelle FasanoDirector, Business Development, Life Sciences and health technology
    Montréal International
  • Patrick HupéMedtronic du Canada

The emergence of genomics and specialized medicine: a revolution that is creating business opportunities

  • Martin LeblancPresident and CEO
    Caprion Biosciences

    Presentation

The big data applied to innovation in LSHT

  • Yoshua BengioProfesseur titulaire, Département d'informatique et de recherche opérationnelle,
    Chaire de Recherche du Canada sur les algorithmes d'apprentissage statistique
    IVADO

    Presentation

 

In collaboration with:

An initiative organized in association with:

By continuing to use this website, you agree to our Privacy Policy and the use of cookies to offer you content and services tailored to your interests. Learn more about our Privacy Policy